BSTC

BioSpecifics Technologies Corp Press Releases

$38.43
*  
0.43
1.11%
Get BSTC Alerts
*Delayed - data as of Nov. 28, 2014 10:48 ET  -  Find a broker to begin trading BSTC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BSTC Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015
11/21/2014 8:30:00 AM - PR Newswire


BioSpecifics Technologies Corp. Announces New Data on XIAFLEX® for Peyronie''s Disease Presented at SMSNA Scientific Meeting
11/21/2014 8:30:00 AM - PR Newswire


BioSpecifics Technologies Corp. to Present at the Stifel 2014 Healthcare Conference
11/12/2014 4:01:00 PM - PR Newswire
▼-1.49 % Price Change since this news event. The Volume Ratio is 1.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BioSpecifics Technologies Corp. Reports Third Quarter 2014 Financial Results
11/10/2014 8:00:00 AM - PR Newswire
▼-2.34 % Price Change since this news event. The Volume Ratio is 1.44.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2014 Financial Results on Monday, November 10, 2014
11/3/2014 8:30:00 AM - PR Newswire
▼-4.21 % Price Change since this news event. The Volume Ratio is 0.74.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BioSpecifics Technologies Corp. Announces FDA Approval of sBLA for XIAFLEX® for the Concurrent Treatment of Two Dupuytren's Contracture Cords
10/21/2014 8:00:00 AM - PR Newswire
▲8.31 % Price Change since this news event. The Volume Ratio is 2.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BioSpecifics Technologies Corp. Announces Presentation of Encouraging Preclinical Data for CCH from Collaborative Uterine Fibroid Study with Duke Medicine
10/16/2014 8:30:00 AM - PR Newswire
▲11.10 % Price Change since this news event. The Volume Ratio is 0.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BioSpecifics Technologies Corp. Announces Sudden Passing of Director Max Link, Ph.D.
10/8/2014 4:05:00 PM - PR Newswire
▲6.75 % Price Change since this news event. The Volume Ratio is 0.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference
9/19/2014 8:30:00 AM - PR Newswire


BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren''s Contracture Presented at American Society for Surgery of the Hand Annual Meeting
9/18/2014 4:17:00 PM - PR Newswire


BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting
9/18/2014 4:17:00 PM - PR Newswire


BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences
9/2/2014 8:00:00 AM - PR Newswire